
Join us now
The Calcitonin Gene-Related Peptide (CGRP) Forum has been established by an international group of clinicians and researchers. It provides all healthcare professionals with open and free access to independent news, information, comment and resources about the exciting potential of CGRP as a novel therapeutic target for the prevention of migraine in millions of people worldwide.

Real World Experience
Find out how other clinicians are using anti-CGRP therapies in their daily practice. Catch up with the latest real world data and share your experiences with colleagues around the world.
Read more
Is anti-CGRP therapy approved for your patients?
Check back regularly at our expert guide to see the regulatory status and approved indications for anti-CGRP therapies worldwide.
Read More Become a member
Meet the Expert
Through videos in English and the Expert’s local language, with complementary downloadable slides, fact sheets and reimbursement guides, leading migraine specialists from around the world address issues related to migraine treatment, with a focus on anti-CGRP therapies.
Read MoreFrom the Editors
Our distinguished Editors discuss the latest developments and provide their views:Will CGRP antibodies put an end to migraine?View all articlesTrials
Easy-to-access digests of all the key trials completed & ongoing:Eptinezumab (ALD403)Erenumab (AMG 334)Galcanezumab (LY2951742)Fremanezumab (TEV-48125)View all TrialsMeeting Reports
Highlights from the latest meetings:16th European Headache Congress Migraine Trust International Symposium 2022 8th Congress of the European Academy of Neurology View all meeting reports